Moldova latest patents query
The latest invention patents collect the data information of Moldova invention patents from 2000 to 2024, typesetting according to the date of patent publication, including patent number, application date, invention Bibliographic data, abstracts, and specification data of people are convenient for scientific researchers to quickly browse and search for patents.
Modified release pharmaceutical formulations comprising deferiprone
UndeterminedMDE20250169A1
Owner:CHIESI FARMACEUTICI SPA
Arc-resistant louvers assembly applied to a ventilation system of an electrical enclosure
PendingMDE20250702A1
Owner:WEG DRIVES & CONTROLS AUTOMAC O LTDA
A communication assembly for an electrical connection system
UndeterminedMDE20250113A1
Owner:CONNEC PTY LTD
Compositions of growth factor for the treatment of eye disease
UndeterminedMDE20250509A1
Owner:CLARIS BIOTHERAPEUTICS INC
Process for preparing phosphorodiamidate morpholino oligomers
UndeterminedMDE20250419A1
Owner:SAREPTA THERAPEUTICS INC
5H-Pyrrolo[2,3-d]pyrimidin-6(7H)-one and crystal of salt thereof
UndeterminedMDE20250388A1
Owner:TAIHO PHARMA CO LTD
Orally disintegrating pharmaceutical tablet containing cariprazine
UndeterminedMDE20250469A1
Owner:RICHTER GEDEON NYRT
System and method for medical practice analysis and management
UndeterminedMDE20250452A1
Owner:RAREBREED VETERINARY PARTNERS INC
Method for manufacturing a rail fastening, method for increasing the vibration strength of a tension spring for holding down a track body element and rail fastening
UndeterminedMDE20250531A1
Owner:VOESTALPINE TURNOUT TECH ZELTWEG GMBH +1
Systems and methods for producing negative carbon intensity hydrocarbon products
UndeterminedMDE20250559A1
Owner:INFINIUM TECHNOLOGY LLC
Cannabinoid type 1 receptor binding proteins and uses thereof
UndeterminedMDE20250453A1
Owner:AMGEN INC
Methods for preventing or treating allergy by administering an IL-4R antagonist
UndeterminedMDE20250595A1
Owner:REGENERON PHARMACEUTICALS INC +1
New spirocyclohexane derivatives, pharmaceutical compositions containing them and their uses as anti-apoptotic inhibitors
UndeterminedMDE20250380A1
Owner:LES LAB SERVIER SA +1
Combination therapies including metal channel activators
UndeterminedMDE20250560A1
Owner:BIOHAVEN THERAPEUTICS LTD
BCMA-targeted CAR-T cell therapy for multiple myeloma
UndeterminedMDE20250052A1
Owner:JANSSEN BIOTECH INC +2
Electronic sensor for an electric motor and electric motor thereof
UndeterminedMDE20250118A1
Owner:SIMOTOP GRP SPA
Autonomous agricultural robot for cutting basal shoots and associated method
UndeterminedMDE20250226A1
Owner:ASSOC NAT DES PRODUCTEURS DE NOISETTES +1
Novel proteins and nucleic acid sequences and use thereof in the prophylaxis and / or treatment of congenital muscular dystrophies
UndeterminedMDE20250041A1
Owner:UNIVERSITY OF BASEL
Sol-gel photocatalytic transparent water-based coating
UndeterminedMDE20250645A1
Owner:THE BLUE PLANET SPA
Internal ribosome entry site (IRES), plasmid vector and circular mRNA for enhancing protein expression
UndeterminedMDE20250107A1
Owner:BIO ADVENTURE CO LTD +1
Inhibiting ataxia telangiectasia and Rad3-related protein (ATR)
UndeterminedMDE20250598A1
Owner:JAZZ PHARMACEUTICALS THERAPEUTICS INC
Method of assessing growth hormone deficiency in humans by a macimorelin containing composition
UndeterminedMDE20250510A1
Owner:AETERNA ZENTARIS GMBH
Novel processes and intermediates for the preparation of soluble guanylate cyclase stimulators
UndeterminedMDE20250495A1
Owner:CYCLERION THERAPEUTICS INC
Passive and forced synthesis of Mg(OH)2 for the purpose of supplying magnesium-based capture of CO2
UndeterminedMDE20250522A1
Owner:SKYONIC
2-Methyl-4-phenylpiperidin-4-ol derivatives as inhibitors of APOL1 and methods of using same
UndeterminedMDE20241124A1
Owner:VERTEX PHARMACEUTICALS INC
Compositions and methods for inhibiting MAPT expression
UndeterminedMDE20250249A1
Owner:DICERNA PHARMACEUTICALS INC
Formulations of human anti-RANKL antibodies, and methods of using the same
PendingMDE20250923A1
Owner:AMGEN INC
Anti-FcRn antibody or antigen binding fragment thereof with improved stability
UndeterminedMDE20250307A1
Owner:HANALL PHARMA CO LTD +1
Device for capping an access opening edge of a packaging body
UndeterminedMDE20250578A1
Owner:COUDERT CONSTR
Sugar beet pulp with improved water holding capacity
UndeterminedMDE20250238A1
Owner:KONINK COOPERATIE COSUN U A
Clamping spring for holding down a track body element
PendingMDE20250774A1
Owner:VOESTALPINE TURNOUT TECH ZELTWEG GMBH +1
T-type calcium channel modulators comprising an azaspirononane core and methods of use thereof
UndeterminedMDE20250151A1
Owner:PRAXIS PRECISION MEDICINES INC
Targeted protein degradation of PARP14 for use in therapy
UndeterminedMDE20250441A1
Owner:ABBVIE OPERATIONS SINGAPORE PTE LTD
Processes for the preparation of N-(1- methylcyclopropyl)-2-(3 -pyridinyl)-2H- indazole-4-carboxamide and intermediates thereof
UndeterminedMDE20250009A1
Owner:FMC CORP
RNA-guided nucleases and active fragments and variants thereof and methods of use
UndeterminedMDE20250643A1
Owner:LIFEEDIT THERAPEUTICS INC
Binding agents capable of binding to CD27 in combination therapy
UndeterminedMDE20250246A1
Owner:GENMAB AS +1
Acetyl-leucine or a pharmaceutically acceptable salt thereof for improved mobility and cognitive function
PendingMDE20250843A1
Owner:INTRABIO LTD
Methods of treating non-small cell lung cancer using mesenchymal epithelial transition factor (MET)-targeted agents
UndeterminedMDE20250534A1
Owner:REGENERON PHARMACEUTICALS INC
Methods and compositions for a universal and long-lasting vaccine
UndeterminedMDE20250286A1
Owner:ZHANG GONGYI
Combustion device with a system of pulse hot cyclones of vacuum type with controlled access of oxygen and function of heat generation
UndeterminedMDE20250527A1
Owner:CHERNENKO TARAS OLEKSANDROVYCH +3
Method for producing 7H-pyrrolo[2,3-d]pyrimidine-4-amine derivative
UndeterminedMDE20250200A1
Owner:TAIHO PHARMA CO LTD
A system for displaying interactive training scenario and for determining the position of relevant objects in a training range and a method of system set up and calibration
UndeterminedMDE20250292A1
Owner:GUARDIARIS D O O
Device for dual dosing in an automated overhead conveyor of the meat industry ending in two independent hooks
UndeterminedMDE20250017A1
Owner:VARGAS JIMENEZ DANIEL
Device and method for storing and / or dosing a melted product
UndeterminedMDE20250018A1
Owner:NOE SEDA
Methods of administering belumosudil for treatment of chronic graft versus host disease in patient subpopulations
UndeterminedMDE20250400A1
Owner:KADMON CORP LLC
Device for aligning tiles
UndeterminedMDE20250162A1
Owner:GLAS-HIT EKSPORT IMPORT MGR INZ JOANNA CHUDY PL
7-Benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapy
PendingMDE20250898A1
Owner:ONCOCEUTICS INC
Methods for treating polysorbate-containing protein formulations
UndeterminedMDE20250440A1
Owner:JANSSEN BIOTECH INC
Hybrid mushroom strain B19414 and methods and uses therefor
UndeterminedMDE20250111A1
Owner:SYLVAN AMERICA INC
New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases
PendingMDE20250869A1
Owner:BOEHRINGER INGELHEIM INT GMBH
Strap tensioning assembly and rigid cover comprising such strap tensioning assembly
UndeterminedMDE20250404A1
Owner:SMART FLOW EURO
Compositions and methods for genomic editing
UndeterminedMDE20250351A1
Owner:INTELLIA THERAPEUTICS INC
Compositions and methods for treating non-age-associated hearing impairment in a human subject
UndeterminedMDE20250283A1
Owner:AKOUOS INC
Apparatus and method for reducing the water content in vegetal or animal inorganic and / or organic compounds
UndeterminedMDE20250409A1
Owner:WEALTH & RES TRADING LTD
Anti-chemokin like receptor 1 antibodies and their therapeutic applications
PendingMDE20250922A1
Owner:OSE IMMUNOTHERAPEUTICS SA
Microtubule associated protein tau (MAPT) iRNA agent compositions and methods of use thereof
UndeterminedMDE20241131A1
Owner:ALNYLAM PHARMACEUTICALS INC +1
Pyrrolotriazine derivatives for treating KIT- and PDGFRα-mediated diseases
UndeterminedMDE20250639A1
Owner:BLUEPRINT MEDICINES CORP
Triple uptake inhibitor for the treatment of atypical depression
UndeterminedMDE20250042A1
Owner:NOEMA PHARMA AG
Connector for connecting a duct for circulating a fluid to a utility and related fixing system
UndeterminedMDE20250170A1
Owner:IVAR SPA
Method of treating mild to moderate psoriasis with IL-23 specific antibody
UndeterminedMDE20250121A1
Owner:JANSSEN BIOTECH INC
Highly concentrated low viscosity MASP-2 inhibitory antibody formulations, kits, and methods
UndeterminedMDE20250542A1
Owner:OMEROS CORP
Recanalization devices and associated systems and methods
UndeterminedMDE20250575A1
Owner:STRYKER CORP
17B-Hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof
UndeterminedMDE20250485A1
Owner:REGENERON PHARMACEUTICALS INC
Crystalline forms of a PCSK9 inhibitor, compositions and uses
UndeterminedMDE20250505A1
Owner:MERCK SHARP & DOHME LLC +1
Pharmaceutical compositions and uses directed to lysosomal storage disorders
UndeterminedMDE20250034A1
Owner:INTRABIO LTD
Graded absorption ammonia method-based decarburization apparatus and method
UndeterminedMDE20250274A1
Owner:JIANGNAN ENVIRONMENTAL TECHNOLOGY INC
Gonadotropin-releasing hormone antagonist dosing regimens for treating uterine fibroids and reducing menstrual blood loss
UndeterminedMDE20250188A1
Owner:KISSEI PHARMACEUTICAL CO LTD
Method and apparatus for waste heat recovery in ammonia-based desulfurization and decarbonization system
UndeterminedMDE20250277A1
Owner:JIANGNAN ENVIRONMENTAL TECHNOLOGY INC
Materials and methods for the treatment of EIF2B5 mutations and diseases resulting therefrom
UndeterminedMDE20250054A1
Owner:RESEARCH INSTITUTE AT NATIONWIDE CHILDRENS HOSPITAL US +1
Methods and compositions for treating cancers by modulating the expression and / or activity of STUB1
UndeterminedMDE20250540A1
Owner:PRESIDENT & FELLOWS OF HARVARD COLLEGE
Engineered polynucleotides for cell selective expression
UndeterminedMDE20250449A1
Owner:MODERNATX INC
Anti-human interleukin 36 receptor monoclonal antibody and use thereof
UndeterminedMDE20250511A1
Owner:QYUNS THERAPEUTICS CO LTD
Combination therapy comprising SIRP alpha fusion protein and anti-CD19 antibody for treatment of cancer
UndeterminedMDE20250338A1
Owner:INCYTE CORP
Method for reducing contamination in agricultural and fish products using H2O2
UndeterminedMDE20250135A1
Owner:AGROETIKA S DE R L DE C V
RNA compositions for delivery of monkeypox antigens and related methods
UndeterminedMDE20250305A1
Owner:BIONTECH SE
The preparation of N-(1-methylcyclopropyl)-2-(3-pyridinyl)-2H-indazole-4-carboxamide and intermediates thereof
UndeterminedMDE20250010A1
Owner:FMC CORP
Heteroaromatic compounds for the treatment of neurological disorders
UndeterminedMDE20250516A1
Owner:SUVEN LIFE SCI LTD
Compounds and compositions and uses thereof
UndeterminedMDE20250640A1
Owner:SUMITOMO PHARMA AMERICA INC +1
Di-cyclopropyl based IL-17A modulators and uses thereof
UndeterminedMDE20250026A1
Owner:DICE ALPHA INC
Use of buloxibutid for the treatment of idiopathic pulmonary fibrosis
UndeterminedMDE20241117A1
Owner:VICORE PHARMA AB
Monohydrate and crystalline forms of 6-[(3s,4s)-4-methyl-1- (pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl- 7h-imid azo [1,5- a] pyrazin-8-one
UndeterminedMDE20250040A1
Owner:CARDURION PHARMA INC
Oral solid pharmaceutical formulation comprising methadone / levomethadone and optionally naloxone
UndeterminedMDE20250528A1
Owner:L MOLTENI & C DEI FRAT ALITTI SOC DI ESERCIZIO SPA
Combination therapies including metal channel activators and NMDA receptor antagonists
UndeterminedMDE20250539A1
Owner:BIOHAVEN THERAPEUTICS LTD
Mavacamten for use in the treatment of hypertrophic cardiomyopathy
PendingMDE20250934A1
Owner:MYOKARDIA INC
Processes for crystallization of amorphous pesticides and formulations thereof
UndeterminedMDE20250108A1
Owner:FMC CORP
An HDAC inhibitor for treating cancer with a modified STK11 activity or expression
UndeterminedMDE20250471A1
Owner:TANGO THERAPEUTICS INC
System for preparing orders for products stored in a multi-level warehouse and picked by a plurality of autonomous mobile robots
UndeterminedMDE20250480A1
Owner:MOVU FRANCE
Hydrometallurgical process for the selective recovery of vanadium, molybdenum and other base metals from various types of industrial waste
UndeterminedMDE20241119A1
Owner:ORIM SPA
Viral particles retargeted to transferrin receptor 1
UndeterminedMDE20250448A1
Owner:REGENERON PHARMACEUTICALS INC
RNAi constructs and methods for inhibiting FAM13A expression
UndeterminedMDE20250439A1
Owner:AMGEN INC
Pyrazolopyridine derivative having GLP-1 receptor agonist effect
UndeterminedMDE20250186A1
Owner:CHUGAI PHARMA CO LTD
Actin-binding LIM protein 3 (ABLIM3) iRNA agent compositions and methods of use thereof
UndeterminedMDE20250236A1
Owner:ALNYLAM PHARMACEUTICALS INC
New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases
UndeterminedMDE20250600A1
Owner:BOEHRINGER INGELHEIM INT GMBH
Humanized antibody that bonds to Eva1 protein or functional fragment thereof, antibody-drug conjugate and chimeric antigen receptor
UndeterminedMDE20250060A1
Owner:CURED INC +2
A controlled release, antimicrobial gel for the treatment of vaginal infections
UndeterminedMDE20250341A1
Owner:SPV HEALTHCARE LTD